Rheumatoid arthritis trials in Germany

In Germany 45 Also abroad 351

45 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
Where
Frankfurt Am Main, Kiel
Age
18 years and over
People
19 worldwide
Run by
AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-523127-21-00 · EU 2025-523127-21-00
Phase 1/2Not yet taking people in Germany
An open-label phase I/II, single-center, interventional singlearm basket trial of UKT-CART19.1 in patients with relapsed/refractory autoimmune diseases
Where
Tuebingen
Age
18 years and over
People
36
Run by
Universitaetsklinikum Tuebingen AöR
See details and how to join2024-519491-60-00 · EU 2024-519491-60-00
Phase 4Taking people
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
Where
Berlin, Bonn
Age
18 years and over
People
197 worldwide
Run by
Queen Mary University Of London
See details and how to join2022-502021-18-00 · EU 2022-502021-18-00
Phase 2Taking people
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Where
Bonn, Munich
Age
18 years and over
People
90 worldwide
Run by
Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00
Phase 1Taking people
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Where
Berlin, Dresden, Duesseldorf, Hamburg, Kiel
Age
18 years and over
People
125 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00
No phaseTaking people
Clinical Outcomes Study of the Nexel Total Elbow
Where
Pforzheim
Age
18 years and over
People
134 worldwide
Run by
Zimmer Biomet
See details and how to joinNCT02469662
Phase 1Taking people
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Where
Berlin
Age
18 years to 75 years
People
141 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07258849 · EU 2025-523980-39-00
Phase 1Taking people
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Where
Cologne, Duesseldorf, Jena, Mainz
Age
18 years to 70 years
People
44 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00
Phase 1Taking people
A placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009
Where
Erlangen, Frankfurt Am Main
Age
18 years and over
People
78 worldwide
Run by
Aboleris Holdco
See details and how to join2024-517547-31-00 · EU 2024-517547-31-00
Phase 1Taking people
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
Where
Jena, Mainz
Age
18 years and over
People
40 worldwide
Run by
Novartis Pharma AG
See details and how to join2024-520196-27-00 · EU 2024-520196-27-00
No phaseTaking people
Comparative Study of Navigation-assisted OrthoPilot® Elite and Robotic-assisted MAKO® Total Knee Arthroplasty
Where
Ulm
Age
18 years to 90 years
People
140
Run by
Aesculap AG
See details and how to joinNCT05980442
No phaseTaking people
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Where
Dresden, Eisenberg, Konstanz
Age
18 years and over
People
600 worldwide
Run by
Aesculap AG
See details and how to joinNCT05302934
Phase 2/3Taking people
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Where
Berlin, Bochum, Hamburg, Hanover
Age
18 years and over
People
70 worldwide
Run by
Kyverna Therapeutics
See details and how to joinNCT07403188 · EU 2024-511198-31-00
No phaseTaking people
Study to Evaluate the Performance of Navigated TKA With OrthoPilot® pheno4u TKA Level 1
Where
Berlin, Dresden, Konstanz
Age
18 years to 80 years
People
120 worldwide
Run by
Aesculap AG
See details and how to joinNCT06955481
No phaseTaking people
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Where
Bonn
Age
18 years and over
People
120
Run by
University of Bonn
See details and how to joinNCT07150000
No phaseTaking people
AYLo - AutoimmunitY and Loss of y
Where
Bonn
Age
50 years and over
People
500
Run by
University of Bonn
See details and how to joinNCT06696027
Phase 3Taking people
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
Where
Freiburg im Breisgau, Heidelberg, Mainz
Age
18 years and over
People
154 worldwide
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT05092984 · EU 2024-516884-10-00
No phaseTaking people
Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis
Where
Würzburg
Age
18 years to 99 years
People
52
Run by
Wuerzburg University Hospital
See details and how to joinNCT06492200
No phaseEnrolling by invitation
Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components
Where
Buxtehude
Age
21 years and over
People
143
Run by
MicroPort Orthopedics Inc.
See details and how to joinNCT03576573
No phaseEnrolling by invitation
Juvenile Inflammatory Rheumatism (JIR) Cohorte
Where
Münster
People
15,000 worldwide
Run by
Michaël Hofer
See details and how to joinNCT02377245